ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
57,682.89
-0.95%
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs Yen
155.274
-0.28%
Brent Oil
84.095
0.66%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Sunshine Biopharma Inc (SBFM)

  7. Sunshine Biopharma Inc (SBFM) ニュース

SBFM

Sunshine Biopharma (SBFM)

Sunshine Biopharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SBFM
日付受信時刻ニュースソース見出しコード企業名
2024/03/0706 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2024/03/0606 : 37Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
2024/03/0606 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
2024/02/2406 : 03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
2024/02/2206 : 28Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
2024/02/2122 : 24Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
2024/02/1707 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2024/02/1601 : 39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2024/02/1505 : 53Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
2024/02/1501 : 18Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SBFMSunshine Biopharma Inc
2024/02/1314 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SBFMSunshine Biopharma Inc
2024/02/1306 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
2024/02/1223 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2024/02/1007 : 17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SBFMSunshine Biopharma Inc
2024/02/0922 : 59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
2024/02/0206 : 17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SBFMSunshine Biopharma Inc
2024/01/3102 : 38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2024/01/0822 : 10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SBFMSunshine Biopharma Inc
2023/12/0806 : 59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2023/12/0422 : 30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMSunshine Biopharma Inc
2023/11/1323 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2023/11/1322 : 00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMSunshine Biopharma Inc
2023/11/0301 : 18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2023/10/2102 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2023/10/2001 : 10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SBFMSunshine Biopharma Inc
2023/10/1902 : 32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
2023/10/1323 : 44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
2023/09/0605 : 20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
2023/08/2604 : 16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
2023/08/1122 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SBFM

最近閲覧した銘柄

NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
FX
USDJPY
US Dollar vs Yen
NYSE
JPM
JP Morgan Chase
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
NYSE
CVX
Chevron
AMEX
XLV
Health Care Select Sector
FX
USDGBP
US Dollar vs Sterling
COIN
BTCUSD
Bitcoin
CCOM
SILVER
SILVER
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有